Analysis of the Influencing Factors of Tumor Volume, Body Immunity, and Poor Prognosis after 125I Particle Therapy for Differentiated Thyroid Cancer
Objective. To analyze the influencing factors of tumor volume, body immunity, and poor prognosis after 125I particle therapy for differentiated thyroid cancer. Methods. A total of 104 patients with differentiated TC who were treated with 125I particles during January 2020 to January 2021 was picked....
Saved in:
| Main Authors: | Liling Tan, Zhijun Chen, Wenjun Wang, Yu Su, Zhen Wu, Ling Yi, Zhipeng Zheng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2023/8130422 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of anlotinib combined with 125I seed implantation for iodine-refractory thyroid cancer
by: Zhijun Chen, et al.
Published: (2025-08-01) -
Carbohydrate antigen-125 (CA125): a marker of right ventricular dysfunction and poor prognosis in heart failure with preserved ejection fraction
by: Sher May Ng, et al.
Published: (2025-10-01) -
Results of treatment of patients with poorly differentiated carcinoma of the thyroid gland
by: P. A. Isaev, et al.
Published: (2023-03-01) -
High GOLT1A expression induces poor prognosis in papillary thyroid carcinoma
by: Tianjiao Ding, et al.
Published: (2025-07-01) -
Lenvatinib Administered via Nasogastric Tube in Poorly Differentiated Thyroid Cancer
by: Eleonora Molinaro, et al.
Published: (2019-01-01)